We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.84%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$16.8B
AUM Growth
+$5.61B
Cap. Flow
+$4.76B
Cap. Flow %
28.29%
Top 10 Hldgs %
34.53%
Holding
3,002
New
714
Increased
860
Reduced
861
Closed
563

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.5%
2 Technology 7.92%
3 Financials 7.86%
4 Healthcare 7.07%
5 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMWP
2326
DELISTED
Eros Media World PLC
EMWP
$115K ﹤0.01%
+1,696
New +$79.2K
HIL
2327
DELISTED
Hill International, Inc. Common Stock
HIL
$114K ﹤0.01%
36,219
-26,651
-42% -$79.7K
ADMS
2328
DELISTED
Adamas Pharmaceuticals
ADMS
$114K ﹤0.01%
+30,177
New +$144K
LRFC
2329
DELISTED
Logan Ridge Finance Corp
LRFC
$112K ﹤0.01%
2,139
-2,431
-53% -$124K
CASA
2330
DELISTED
Casa Systems, Inc. Common Stock
CASA
$112K ﹤0.01%
27,383
+16,225
+145% +$77.5K
AQST icon
2331
Aquestive Therapeutics
AQST
$462M
$109K ﹤0.01%
18,650
-22,127
-54% -$115K
MGI
2332
DELISTED
MoneyGram International, Inc. New
MGI
$109K ﹤0.01%
+52,054
New +$167K
AFMD
2333
DELISTED
Affimed
AFMD
$108K ﹤0.01%
+3,945
New +$106K
OVID icon
2334
Ovid Therapeutics
OVID
$435M
$108K ﹤0.01%
+26,029
New +$82.2K
PFX icon
2335
PhenixFIN
PFX
$108K ﹤0.01%
+2,485
New +$109K
FPRX
2336
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$108K ﹤0.01%
23,500
-184,323
-89% -$730K
EPM icon
2337
Evolution Petroleum
EPM
$137M
$104K ﹤0.01%
18,936
-23,564
-55% -$130K
NGVC icon
2338
Vitamin Cottage Natural Grocers
NGVC
$691M
$104K ﹤0.01%
+10,537
New +$96.8K
ZYNE
2339
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$104K ﹤0.01%
17,254
+5,345
+45% +$36.6K
ASPU
2340
DELISTED
ASPEN GROUP, INC.
ASPU
$104K ﹤0.01%
+12,963
New +$84.6K
WMC
2341
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$104K ﹤0.01%
1,008
-3,469
-77% -$352K
SACH
2342
Sachem Capital Corp
SACH
$38.4M
$103K ﹤0.01%
23,717
-9,815
-29% -$43.8K
CMRX
2343
DELISTED
Chimerix, Inc.
CMRX
$103K ﹤0.01%
+50,880
New +$93.8K
PRTK
2344
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$103K ﹤0.01%
+25,511
New +$88.5K
SURF
2345
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$102K ﹤0.01%
+54,479
New +$90.8K
BHAT
2346
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
$101K ﹤0.01%
+1
New +$142K
CLNE icon
2347
Clean Energy Fuels
CLNE
$447M
$101K ﹤0.01%
43,110
-140,003
-76% -$297K
GNSS icon
2348
Genasys
GNSS
$75.6M
$99K ﹤0.01%
30,164
+4,580
+18% +$15.5K
NIO icon
2349
NIO
NIO
$11.3B
$99K ﹤0.01%
24,614
-97,627
-80% -$196K
EGY icon
2350
Vaalco Energy
EGY
$594M
$96K ﹤0.01%
+43,195
New +$85.6K

Similar funds

Squarepoint's Q4 2019 Portfolio in Review

As of Q4 2019, Squarepoint held 3,002 positions worth $16.8B, up 50% from $11.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Squarepoint deployed $4.76B of net new capital in Q4 2019, opening 714 new positions and adding to 860 existing holdings. Its largest new stake was State Street Technology Select Sector SPDR ETF: 13,207,978 shares worth $605M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $89.1M trimmed.

  • Squarepoint's largest Q4 2019 buy was State Street Technology Select Sector SPDR ETF: 13,207,978 shares worth $605M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $3.61B increase.
  • Squarepoint's biggest Q4 2019 reduction was Starbucks, cutting an estimated $89.1M.
  • Squarepoint fully exited State Street Communication Services Select Sector SPDR ETF in Q4 2019, selling an estimated $161M.
  • Squarepoint's ten largest holdings make up 35% of its $16.8B portfolio in Q4 2019.
  • Squarepoint opened 714 new positions and closed 563 in Q4 2019.
  • Squarepoint's portfolio value rose 50% quarter-over-quarter to $16.8B.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.